Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04ZTY
|
||||
Former ID |
DAP001104
|
||||
Drug Name |
Voglibose
|
||||
Synonyms |
Basen; Glustat; Vocarb; Basen OD; A-71100; AO-128; Basen (TN); Basen (Takeda Chemical Industries); Volix (Ranbaxy labs);Voglibose (JP15/USAN/INN); N-(1,3-Dihydroxyprop-2-yl)valiolamine; (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; (1S,2S,3R,4S,5S)-5-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Approved | [536361] | ||
Therapeutic Class |
Hypoglycemic Agents
|
||||
Company |
Takeda
|
||||
Structure |
Download2D MOL |
||||
Formula |
C10H21NO7
|
||||
Canonical SMILES |
C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO
|
||||
InChI |
1S/C10H21NO7/c12-2-5(3-13)11-6-1-10(18,4-14)9(17)8(16)7(6)15/h5-9,11-18H,1-4H2/t6-,7-,8+,9-,10-/m0/s1
|
||||
InChIKey |
FZNCGRZWXLXZSZ-CIQUZCHMSA-N
|
||||
CAS Number |
CAS 83480-29-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7848728, 10299466, 12013776, 15070756, 36887136, 46504462, 48414634, 49835305, 57404590, 80611090, 103624146, 104111539, 104631150, 119525753, 121264490, 126592896, 134223911, 134338349, 135027174, 135812317, 136367734, 136948052, 137002784, 139694698, 144205773, 152090258, 152344538, 160967826, 164178111, 164814716, 170465993, 179151268, 184545240, 198946321, 210279172, 210281495, 226397450, 241164518, 249726430, 251915707, 251917057, 252157387, 252216589, 252359063, 252451111
|
||||
SuperDrug ATC ID |
A10BF03
|
||||
SuperDrug CAS ID |
cas=083480299
|
||||
Target and Pathway | |||||
Target(s) | Maltase-glucoamylase, intestinal | Target Info | Inhibitor | [537567] | |
PathWhiz Pathway | Starch and Sucrose Metabolism | ||||
WikiPathways | Metabolism of carbohydrates | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.